BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eissa NG, Elsabahy M, Allam A. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. Int J Pharm 2021;597:120317. [PMID: 33540005 DOI: 10.1016/j.ijpharm.2021.120317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu F, Xu B, Chen H, Ju X, Gonzalez de Mejia E. Enhancement of DPP-IV inhibitory activity and the capacity for enabling GLP-1 secretion through RADA16-assisted molecular designed rapeseed peptide nanogels. Food Funct 2022;13:5215-28. [PMID: 35438092 DOI: 10.1039/d1fo04367f] [Reference Citation Analysis]
2 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
3 Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes: A focus on thin-film hydration method. Methods 2021:S1046-2023(21)00130-4. [PMID: 34000392 DOI: 10.1016/j.ymeth.2021.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Tan H, Su W, Zhang W, Zhang J, Sattler M, Zou P. Generation of novel long-acting GLP-1R agonists using DARPins as a scaffold. Int J Pharm 2021;607:121043. [PMID: 34450223 DOI: 10.1016/j.ijpharm.2021.121043] [Reference Citation Analysis]
5 Gomaa E, Fathi HA, Eissa NG, Elsabahy M. Methods for preparation of nanostructured lipid carriers. Methods 2021:S1046-2023(21)00129-8. [PMID: 33992771 DOI: 10.1016/j.ymeth.2021.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]